Precision’s Tandy Tipps tells you how to match the right sites to the right trials
The combination of ever more personalized medicine, as well as complex adaptive study designs, means that oncology developers can now run successful clinical trials with smaller, more targeted subsets of patients. However, with the benefits, personalization and adaptive design also bring new challenges, with greater competition for patient access and increased complexity for sites. Matching the right sites to the right trials is, therefore, more important than ever for oncology trials.